$330 Million is the total value of March Altus Capital Management LP's 28 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DXCM | New | DEXCOM INC | $29,562,000 | – | 834,838 | +100.0% | 8.95% | – |
| MON | New | MONSANTO CO NEW | $23,192,000 | – | 198,988 | +100.0% | 7.02% | – |
| ALKS | New | ALKERMES PLC | $18,820,000 | – | 462,853 | +100.0% | 5.70% | – |
| HCA | New | HCA HOLDINGS INC | $17,528,000 | – | 367,390 | +100.0% | 5.31% | – |
| WST | New | WEST PHARMACEUTICAL SVSC INC | $16,541,000 | – | 337,161 | +100.0% | 5.01% | – |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $14,306,000 | – | 756,505 | +100.0% | 4.33% | – |
| AON | New | AON PLC | $12,306,000 | – | 146,694 | +100.0% | 3.73% | – |
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $12,185,000 | – | 255,406 | +100.0% | 3.69% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $12,163,000 | – | 91,411 | +100.0% | 3.68% | – |
| BAX | New | BAXTER INTL INC | $12,127,000 | – | 174,370 | +100.0% | 3.67% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $11,743,000 | – | 144,506 | +100.0% | 3.56% | – |
| AGN | New | ALLERGAN INC | $11,735,000 | – | 105,645 | +100.0% | 3.55% | – |
| HUM | New | HUMANA INC | $11,612,000 | – | 112,502 | +100.0% | 3.52% | – |
| LLY | New | LILLY ELI & CO | $11,569,000 | – | 226,838 | +100.0% | 3.50% | – |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $11,554,000 | – | 221,085 | +100.0% | 3.50% | – |
| EHTH | New | EHEALTH INC | $11,316,000 | – | 243,399 | +100.0% | 3.43% | – |
| PRGO | New | PERRIGO CO | $11,196,000 | – | 72,955 | +100.0% | 3.39% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $11,030,000 | – | 428,023 | +100.0% | 3.34% | – |
| CYBX | New | CYBERONICS INC | $10,933,000 | – | 166,888 | +100.0% | 3.31% | – |
| HLS | New | HEALTHSOUTH CORP | $10,545,000 | – | 316,462 | +100.0% | 3.19% | – |
| ATHN | New | ATHENAHEALTH INC | $8,907,000 | – | 66,226 | +100.0% | 2.70% | – |
| UNIS | New | UNILIFE CORP NEW | $7,381,000 | – | 1,677,433 | +100.0% | 2.24% | – |
| ARAY | New | ACCURAY INC | $5,980,000 | – | 686,569 | +100.0% | 1.81% | – |
| MDCO | New | MEDICINES CO | $5,901,000 | – | 152,809 | +100.0% | 1.79% | – |
| MMC | New | MARSH & MCLENNAN COS INC | $5,820,000 | – | 120,350 | +100.0% | 1.76% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $5,740,000 | – | 51,545 | +100.0% | 1.74% | – |
| ENZY | New | ENZYMOTEC LTD | $5,482,000 | – | 202,962 | +100.0% | 1.66% | – |
| GNMK | New | GENMARK DIAGNOSTICS INC | $2,979,000 | – | 223,818 | +100.0% | 0.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 12 | Q3 2016 | 14.4% |
| LILLY ELI & CO | 12 | Q3 2016 | 20.0% |
| ALEXION PHARMACEUTICALS INC | 11 | Q3 2016 | 15.1% |
| MALLINCKRODT PUB LTD CO | 8 | Q3 2015 | 7.0% |
| UNITED THERAPEUTICS CORP DEL | 7 | Q3 2015 | 11.7% |
| REGENERON PHARMACEUTICALS | 7 | Q3 2016 | 14.6% |
| UNIVERSAL HLTH SVCS INC | 7 | Q2 2015 | 12.1% |
| ZOETIS INC | 7 | Q3 2016 | 5.2% |
| INCYTE CORP | 6 | Q4 2015 | 14.7% |
| EDWARDS LIFESCIENCES CORP | 5 | Q3 2016 | 28.5% |
View March Altus Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-07 |
| 13F-HR | 2016-07-27 |
| 13F-HR | 2016-05-12 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View March Altus Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.